Plexus Corp. (PLXS) fair value analysis

Nasdaq · Updated 2026-09-07

Plexus Corp. is a contract manufacturer that provides electronics manufacturing services and supply chain solutions to companies across various industries. The company operates manufacturing facilities and service centers in multiple countries including the United States, Mexico, China, and other locations worldwide.

Forward Fair Value verdict

Overvalued

Based on TickrTrends' weekly Forward Fair Value model, PLXS is trading at more than a 25% premium to estimated fair value.

PLXS currently ranks #165 of 199 Technology stocks by discount to Forward Fair Value. It has screened as Overvalued for 3 consecutive weekly runs.

Last price: $260.77
Sector: Technology
12-month range: $142.43–$290.17

Derived indicators

Coarse bands from TickrTrends' weekly models; exact figures are part of the full report.

Quality grade: D
Leverage: Low
RSI zone: Neutral
50/200-day trend: Mixed
52-week position: The top quarter of its range

What our data shows for PLXS

Our model validated 17 trailing price-to-earnings windows for PLXS, built from quarterly earnings records.
Shares are trading in the upper third of their 12-month price range of $142.43–$290.17.
The 14-day relative strength index sits at a neutral 38.

The exact numbers are one step away

The precise Forward Fair Value dollar figure for PLXS
Exact discount / premium to today's price
The normalized historical P/E behind the estimate, and how many quarters support it
Forward EPS input and fiscal-year basis
Screeners and rankings across the full S&P 500 and Nasdaq universes

See the exact fair value →

How Forward Fair Value works

TickrTrends computes a Forward Fair Value for every covered stock each week: a conservatively normalized historical price-to-earnings multiple is applied to the analyst-consensus earnings estimate for the next full fiscal year. Every input window is validated for continuity and every result is screened for plausibility before publication.

Recent PLXS news

TickrTrends' derived news-sentiment signal for PLXS is currently mixed, computed from recent coverage.

Plexus Corp (PLXS) Director Karen Rapp Sells 500 Shares (gurufocus.com, 2026-09-01)
TickrTrends take: Plexus Corp director Karen Rapp's recent sale of 500 shares occurs within a context where TickrTrends currently assesses the company as overvalued. Insider selling activity can merit attention from valuation-focused investors monitoring whether company insiders view current price levels as elevated relative to fundamental value. For investors tracking Technology sector positioning, this transaction adds a data point to consider alongside the existing overvaluation assessment.
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (manilatimes.net, 2026-08-07)
TickrTrends take: Pacira BioSciences' inducement grants under Nasdaq rules represent standard equity compensation for new executives, a practice common across the technology sector that can dilute shareholder value over time. Given TickrTrends' current assessment that PLXS trades at overvalued levels, investors focused on valuation metrics should monitor whether such equity grants increase the company's share count materially enough to further pressure per-share earnings. The combination of potentially elevated valuation multiples alongside ongoing equity dilution from inducement grants creates a dynamic that valuation-conscious shareholders typically track closely.
Plexus Corp. (PLXS) Q3 2026 Earnings Call Transcript (seekingalpha.com, 2026-08-01)
TickrTrends take: Plexus Corp operates in the Technology sector where growth expectations and margin performance significantly influence valuation multiples. According to TickrTrends' current assessment, PLXS is trading at levels considered overvalued, which suggests the market may be pricing in optimistic assumptions about future earnings or growth that warrant scrutiny. Valuation-focused investors should closely examine the Q3 earnings discussion for evidence of whether the company's actual financial performance and forward guidance justify its current market price, or whether valuation compression may be more likely than expansion.

What people are saying

Follow the PLXS conversation: Stocktwits · Reddit · X

TickrTrends weekly updates

2026-09-07 — No material change this week: the verdict, bands and grades all held steady.
2026-09-06 — No material change this week: the verdict, bands and grades all held steady.
2026-08-31 — TickrTrends initiated weekly Forward Fair Value coverage of this stock.

Frequently asked questions

Is PLXS stock undervalued?

Based on TickrTrends' Forward Fair Value model (updated 2026-09-07), PLXS is trading at more than a 25% premium to estimated fair value and screens as overvalued. The exact fair value and discount are available to subscribers.

What is PLXS's TickrTrends verdict?

PLXS's current verdict is Overvalued, refreshed with every weekly Forward Fair Value run.

How does PLXS compare to other Technology stocks?

PLXS ranks #165 of 199 Technology stocks in TickrTrends' coverage when sorted by discount to Forward Fair Value.

Is PLXS overbought or oversold?

PLXS's 14-day RSI is in neutral territory - neither overbought nor oversold.

All Technology fair-value coverage →

Head-to-head comparisons

PLXS vs DAVE · PLXS vs DGII · PLXS vs FLEX · PLXS vs HPQ · PLXS vs INTC